You are using an unsupported browser. Please upgrade your browser to a newer version to get the best experience on CypComp Database.
Record Information
Version1.0
Creation Date2019-07-14 16:55:06 UTC
Last Updated2019-10-01 21:42:09 UTC
CypComp IDCC02438
Compound Information
NameReduced haloperidol
Structure ImageWnzbbtjfoioemp fqevstjzsa n
InChIKeyWNZBBTJFOIOEMP-FQEVSTJZSA-N
PubChem ID16048564
CypCompound Information
SetCypBoM Training Set
Bonds of Metabolism (BoMs)
CYP1A2CYP2A6CYP2B6CYP2C8CYP2C9CYP2C19CYP2D6CYP2E1CYP3A4
  • Not Available
  • Not Available
  • Not Available
  • Not Available
  • Not Available
  • Not Available
  • Not Available
  • Not Available
  • <18,20;Oxidation;R1>
  • <12,N;N-Oxidation;R2>
  • <12,8;Oxidation;R2>
  • <8,4;Oxidation;R2>
  • <4,1;Oxidation;R2>
  • <1,5;Oxidation;R2>
  • <5,9;Oxidation;R2>
  • <9,12;Oxidation;R2>
  • <1,2;Reduction;R2>
  • <14,12;Cleavage;R3>
  • <14,H;Oxidation;R3>
References
  1. Fang J, McKay G, Song J, Remillrd A, Li X, Midha K: In vitro characterization of the metabolism of haloperidol using recombinant cytochrome p450 enzymes and human liver microsomes. Drug Metab Dispos. 2001 Dec;29(12):1638-43. [PubMed:11717183 ]
Download FileCC02438.sdf